Details of the Drug
General Information of Drug (ID: DMEJ8YA)
| Drug Name | 
                     JWH-203 
                 | 
            ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
                                         
                        JWH-203; 864445-54-5; 2-(2-Chlorophenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone; UNII-52CP80V8FY; 1-Pentyl-3-(2-chlorophenylacetyl)indole; JWH 203; CHEMBL189035; 52CP80V8FY; 2-(2-chlorophenyl)-1-(1-pentylindol-3-yl)ethanone; JWH203; DEA No. 7203; SCHEMBL16201543; DTXSID00235557; YDINKDBAZJOSLV-UHFFFAOYSA-N; ZINC28457100; BDBM50170357; AKOS022186463; CCG-208745; AJ-83455; AK146159; AX8283836; KB-220910; ST24039182; FT-0670592; A20550; JWH-203 (1-pentyl-3-(2-chlorophenylacetyl)indole; 2-(2-Chlorophenyl)-1-(1-pentylindol-3-yl)methanone
                        
                     
                                     | 
            ||||||||||||||||||||||
| Indication | 
                                                            
  | 
            ||||||||||||||||||||||
| Drug Type | 
                     Small molecular drug 
                 | 
            ||||||||||||||||||||||
| Structure | 
                    ![]()  | 
            ||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 339.9 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | 5.6 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 7 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
| Chemical Identifiers | 
                        
  | 
                ||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT)  | 
                
                    
  | 
            ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
                    
  | 
            ||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


